Selected article for: "enzymatic activity and small molecule"

Author: Amrita Roy; Liangzhong Lim; Shagun Srivastava; Jianxing Song
Title: Unique properties of Zika NS2B-NS3pro complexes as decoded by experiments and MD simulations
  • Document date: 2016_9_28
  • ID: l82aakrk_21
    Snippet: Characterization of the enzymatic inhibition-Previously, a small molecule p-Nitrophenyl-pguanidino benzoate (Fig. 3D ) has been identified to specifically bind to the active site of West Nile NS2B-NS3pro by molecular dynamics (MD) simulations, followed by NMR binding confirmation (19) . Later, this molecule has been extensively demonstrated to bind Dengue (Table 1 ). Most strikingly, as clearly evidenced from Lineweaver-Burk plots for both linked.....
    Document: Characterization of the enzymatic inhibition-Previously, a small molecule p-Nitrophenyl-pguanidino benzoate (Fig. 3D ) has been identified to specifically bind to the active site of West Nile NS2B-NS3pro by molecular dynamics (MD) simulations, followed by NMR binding confirmation (19) . Later, this molecule has been extensively demonstrated to bind Dengue (Table 1 ). Most strikingly, as clearly evidenced from Lineweaver-Burk plots for both linked (Fig. 3E ) and unlinked (Fig. 3G ) Zika complexes, the small molecule acts as a non-competitive inhibitor for both forms. We have searched all literatures citing the original paper (19) , but only found IC50 value of this inhibitor on West Nile NS2B-NS3pro complex (34.2 µM) in the original paper (19) . Therefore, this inhibitor could inhibit the enzymatic activity of Zika NS2B-NS3pro much more potently than that of author/funder. All rights reserved. No reuse allowed without permission.

    Search related documents:
    Co phrase search for related documents
    • active site and enzymatic inhibition: 1, 2, 3
    • active site and Lineweaver Burk plot: 1
    • active site and literature search: 1
    • active site and MD simulation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and molecular dynamic: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and non competitive inhibitor: 1
    • active site and original paper: 1
    • active site and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site bind and enzymatic activity: 1
    • active site bind and MD simulation: 1, 2, 3, 4, 5
    • active site bind and molecular dynamic: 1, 2, 3, 4
    • active site bind and small molecule: 1, 2, 3, 4, 5, 6, 7
    • enzymatic activity and MD simulation: 1, 2
    • enzymatic activity and molecular dynamic: 1, 2
    • enzymatic activity and original paper: 1
    • enzymatic activity and small molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • enzymatic inhibition and small molecule: 1, 2, 3
    • literature search and MD simulation: 1
    • literature search and molecular dynamic: 1